v3.26.3
Stock-Based Compensation (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Retirement Benefits [Abstract]    
Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity and related information:

 

  

Number of

Shares

  

Weighted

Average

Exercise Price

  

Aggregate

Intrinsic Value

(in thousands)

  

Weighted

Average

Remaining Life

 
Outstanding as of December 31, 2025   366,839   $15.2   $3,716,928    8.71 
Granted   401,996   $25.4   $-    - 
Exercised during period   -   $-    -    - 
Forfeited   532   $25.8   $-    - 
Expired   644   $23    -    - 
Outstanding as of June 30, 2026   767,659   $20.4   $1,186,016    9.01 

The following table summarizes the Company’s stock option activity and related information:

 

   Number of Shares   Weighted Average Exercise Price  

Aggregate Intrinsic Value

(in thousands)

   Weighted Average Remaining Life 
Outstanding as of December 31, 2024   251,407   $11.4   $3,737,966    9.30 
Granted   118,641   $23.4   $-    - 
Exercised during period   45   $8.4    -    - 
Forfeited   810   $19.4   $-    - 
Expired   2,354   $27    -    - 
Outstanding as of December 31, 2025   366,839   $15.2   $3,716,928    8.71 
Schedule of Stock Options Valuation Assumptions  

The estimated fair value of stock options was determined using the Black-Scholes option-pricing model with the following weighted-average assumptions:

 

  

Years Ended December 31,

 
   2025   2024 
Expected term of options (years)   5.00-6.65    5.00-6.12 
Expected volatility (%)    39.57-45.07      45.09-45.81  
Risk-free interest rate (%)   3.86    4.57 
Expected dividend yield (%)   —    — 
Schedule of Stock Based Compensation Expenses

Total stock-based compensation expense for the three and six months ended June 30, 2026 and 2025 was as follows (in thousands):

 

   June 30, 2026   June 30, 2025   June 30, 2026   June 30, 2025 
   Three Months Ended   Six Months Ended 
   June 30, 2026   June 30, 2025   June 30, 2026   June 30, 2025 
Cost of sales  $4   $5   $19   $9 
Research and development   35    23    68    59 
Sales and marketing   11    -    18    16 
General and administrative   314    252    462    278 
Total stock-based compensation expense  $364   $280   $567   $362 

Total stock-based compensation expense for years ended December 31, 2025 and 2024 was as follows (in thousands):

 

   2025   2024 
  

Years Ended December 31,

 
   2025   2024 
Cost of sales   16    4 
Research and development   100    153 
Sales and marketing   22    115 
General and administrative   477    689 
Total stock-based compensation expense   615    961